102 related articles for article (PubMed ID: 30003395)
1. Factors associated with long-term survival in central nervous system metastases.
Cacho-Díaz B; Spínola-Maroño H; González-Aguilar A; Arrieta O
J Neurooncol; 2018 Oct; 140(1):159-164. PubMed ID: 30003395
[TBL] [Abstract][Full Text] [Related]
2. Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms.
Cacho-Díaz B; Salmerón-Moreno K; Alvarez-Alvarez A; Mendoza-Olivas LG; Alvarado-Miranda A; Villarreal-Garza C; Reynoso-Noverón N; Chávez-MacGregor M; Meneses-García AA
Cancer; 2020 Aug; 126(15):3456-3463. PubMed ID: 32453447
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and outcome of HER2+ breast cancer with CNS metastases.
Masci G; Agostinetto E; Giordano L; Bottai G; Torrisi R; Losurdo A; De Sanctis R; Navarria P; Scorsetti M; Zuradelli M; de Rose F; Bello L; Santoro A
Future Oncol; 2020 Mar; 16(7):269-279. PubMed ID: 32043375
[No Abstract] [Full Text] [Related]
4. Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort.
Pasquier D; Darlix A; Louvel G; Fraisse J; Jacot W; Brain E; Petit A; Mouret-Reynier MA; Goncalves A; Dalenc F; Deluche E; Fresnel JS; Augereau P; Ferrero JM; Geffrelot J; Fumet JD; Lecouillard I; Cottu P; Petit T; Uwer L; Jouannaud C; Leheurteur M; Dieras V; Robain M; Mouttet-Audouard R; Bachelot T; Courtinard C
Eur J Cancer; 2020 Jan; 125():22-30. PubMed ID: 31835235
[TBL] [Abstract][Full Text] [Related]
5. Prognostic features of endometrial cancer metastasis to the central nervous system.
Kuznicki ML; Mallen A; Ha K; McClung EC; Castaneda AV; Cao B; Fridley BL; Chon HS; Chern JY; Hoffman M; Wenham RM; Matsuo K; Shahzad MMK
PLoS One; 2022; 17(8):e0268794. PubMed ID: 36018828
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of brain metastases in breast cancer patients resulting from neurological symptoms.
Cacho-Díaz B; Spínola-Maroño H; Arrieta VA; Granados-García M; Wegman-Ostrosky T; Mendoza-Olivas LG; Chávez-MacGregor M
Clin Neurol Neurosurg; 2018 Oct; 173():61-64. PubMed ID: 30086430
[TBL] [Abstract][Full Text] [Related]
7. Central Nervous System Metastases in Patients With Cervical Carcinoma.
Cacho-Díaz B; Lorenzana-Mendoza NA; Michel-Ortega RM; Reyes-Soto G; Monroy-Sosa A; Cantú de León D; Martínez-Tláhuel JL; Herrera-Gómez A; Granados-García M
Int J Gynecol Cancer; 2016 Nov; 26(9):1686-1689. PubMed ID: 27654265
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER.
Brufsky AM; Mayer M; Rugo HS; Kaufman PA; Tan-Chiu E; Tripathy D; Tudor IC; Wang LI; Brammer MG; Shing M; Yood MU; Yardley DA
Clin Cancer Res; 2011 Jul; 17(14):4834-43. PubMed ID: 21768129
[TBL] [Abstract][Full Text] [Related]
9. Clinical presentation, risk factors and outcome of central nervous system metastasis vs stroke in cancer patients.
Cacho-Díaz B; Spínola-Maroño H; Mendoza-Olivas LG
Curr Probl Cancer; 2019 Aug; 43(4):324-330. PubMed ID: 30482399
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.
Altundag K; Bondy ML; Mirza NQ; Kau SW; Broglio K; Hortobagyi GN; Rivera E
Cancer; 2007 Dec; 110(12):2640-7. PubMed ID: 17960791
[TBL] [Abstract][Full Text] [Related]
12. Metastatic breast cancer subtypes and central nervous system metastases.
Aversa C; Rossi V; Geuna E; Martinello R; Milani A; Redana S; Valabrega G; Aglietta M; Montemurro F
Breast; 2014 Oct; 23(5):623-8. PubMed ID: 24993072
[TBL] [Abstract][Full Text] [Related]
13. The pathological spectrum of solid CNS metastases in the pediatric population.
Wiens AL; Hattab EM
J Neurosurg Pediatr; 2014 Aug; 14(2):129-35. PubMed ID: 24926970
[TBL] [Abstract][Full Text] [Related]
14. Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma.
Wiens AL; Martin SE; Bertsch EC; Vance GH; Stohler RA; Cheng L; Badve S; Hattab EM
Arch Pathol Lab Med; 2014 Feb; 138(2):175-81. PubMed ID: 24476516
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors.
Gori S; Rimondini S; De Angelis V; Colozza M; Bisagni G; Moretti G; Sidoni A; Basurto C; Aristei C; Anastasi P; Crinò L
Oncologist; 2007 Jul; 12(7):766-73. PubMed ID: 17673608
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer subtypes and outcomes of central nervous system metastases.
Arslan UY; Oksuzoglu B; Aksoy S; Harputluoglu H; Turker I; Ozisik Y; Dizdar O; Altundag K; Alkis N; Zengin N
Breast; 2011 Dec; 20(6):562-7. PubMed ID: 21871802
[TBL] [Abstract][Full Text] [Related]
17. Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.
Suki D; Khoury Abdulla R; Ding M; Khatua S; Sawaya R
J Neurosurg Pediatr; 2014 Oct; 14(4):372-85. PubMed ID: 25127097
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab.
Montagna E; Cancello G; D'Agostino D; Lauria R; Forestieri V; Esposito A; Silvestro L; Accurso A; De Placido S; De Laurentiis M
Cancer Chemother Pharmacol; 2009 Jan; 63(2):275-80. PubMed ID: 18379783
[TBL] [Abstract][Full Text] [Related]
19. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Altundag K
Cancer; 2006 Nov; 107(10):2521-2; author reply 2522. PubMed ID: 17036346
[No Abstract] [Full Text] [Related]
20. Survival of breast cancer patients with synchronous or metachronous central nervous system metastases.
Ho VK; Gijtenbeek JM; Brandsma D; Beerepoot LV; Sonke GS; van der Heiden-van der Loo M
Eur J Cancer; 2015 Nov; 51(17):2508-16. PubMed ID: 26277099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
